Diabetes and critical limb ischemia: The deadly duo in patients with symptomatic peripheral artery disease

Acta Clinica Croatica

Volumn 55, Issue 2, 2016, Pages 240-246

  Vrsalović, Mislav ^a,b   Vučur, Ksenija ^c  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c Institute for Emergency Medicine of the City of Zagreb   (Croatia)

Author keywords

Blood supply; C reactive protein; Diabetes mellitus; Extremities; Inflammation; Ischemia; Mortality; Peripheral arterial disease

Indexed keywords

C REACTIVE PROTEIN;

AGED; ANKLE BRACHIAL INDEX; ARTICLE; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PROGNOSIS; RISK FACTOR; BLOOD; COMPLICATION; DIABETIC ANGIOPATHY; HEART STROKE VOLUME; ISCHEMIA; LEG; METABOLISM; MIDDLE AGED; SURVIVAL RATE; VASCULARIZATION; VERY ELDERLY;

AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; DIABETIC ANGIOPATHIES; FEMALE; HUMANS; ISCHEMIA; LEG; MALE; MIDDLE AGED; PERIPHERAL ARTERIAL DISEASE; STROKE VOLUME; SURVIVAL RATE;

EID: 84994141287     PISSN: 03539466     EISSN: 13339451     Source Type: Journal    
DOI: 10.20471/acc.2016.55.02.09     Document Type: Article

References (38)

1. Gallino A, Aboyans V, Diehm C, Cosentino F, Stricker H, Falk E, et al. Non-coronary atherosclerosis. Eur Heart J. 2014; 35:1112-9, doi: 10.1093/eurheartj/ehu071
2. Suárez C, Zeymer U, Limbourg T, Baumgartner I, Cacoub P, Poldermans D, et al. Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry. Vasc Med. 2010;15:259-65, doi: 10.1177/1358863X10373299
3. van Kuijk JP, Flu WJ, Welten GM, Hoeks SE, Chonchol M, Vidakovic R, et al. Long-term prognosis of patients with peripheral arterial disease with or without polyvascular atherosclerotic disease. Eur Heart J. 2010;31:992-9, doi: 10.1093/eurheartj/ehp553
4. Newman AB, Siscovick DS, Manolio TA, Polak J, Fried LP, Borhani NO, et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation. 1993;88:837-45, doi: 10.1161/01.CIR.88.3.837
5. Murabito JM, D'Agostino RB, Silbershatz H, Wilson WF. Intermittent claudication. A risk profile from The Framingham Heart Study. Circulation. 1997;96:44-9, doi: 10.1161/01. CIR.96.1.44
6. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA. 2002;287:2570-81, doi: 10.1001/jama.287.19.2570
7. Blaslov K, Zibar K, Bulum T, Duvnjak L. Relationship of vascular complications and exenatide therapy failure in type 2 diabetic patients. Acta Clin Croat. 2013;52:328-36.
8. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333-41, http://dx.doi.org/10.2337/diacare.26.12.3333
9. Kamalesh M, Shen J. Diabetes and peripheral arterial disease in men: trends in prevalence, mortality, and effect of concomitant coronary disease. Clin Cardiol. 2009;32:442-6, doi: 10.1002/clc.20564
10. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24:1433-7, http://dx.doi.org/10.2337/diacare.24.8.1433
11. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286:327-34, doi: 10.1001/jama.286.3.327.
12. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation. 1998;97: 425-8, doi: 10.1161/01.CIR.97.5.425
13. Pfützner A, Standl E, Strotmann HJ, Schulze J, Hohberg C, Lübben G, et al. Association of high-sensitive C-reactive protein with advanced stage beta-cell dysfunction and insulin resistance in patients with type 2 diabetes mellitus. Clin Chem Lab Med. 2006;44:556-60, doi: 10.1515/CCLM.2006.108
14. Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes. 2002;51:1596-600, http://dx.doi. org/10.2337/diabetes.51.5.1596
15. Vrsalovic M, Pintaric H, Babic Z, Pavlov M, Vrsalovic Presecki A, Getaldic B, et al. Impact of admission anemia, C-reactive protein and mean platelet volume on short term mortality in patients with acute ST-elevation myocardial infarction treated with primary angioplasty. Clin Biochem. 2012;45:1506-9, doi: 10.1016/j.clinbiochem.2012.05.026
16. Vrsalovic M, Zeljkovic I, Presecki AV, Pintaric H, Kruslin B. C-reactive protein, not cardiac troponin T, improves risk prediction in hypertensives with type A aortic dissection. Blood Press. 2015;24:212-6, doi:10.3109/08037051.2015.1025607
17. Vrsalovic M, Vucur K, Car B, Krcmar T, Vrsalovic Presecki A. C-reactive protein, renal function, and cardiovascular outcome in patients with symptomatic peripheral artery disease and preserved leftventricular systolic function. Croat Med J. 2015; 56:351-6, doi: 10.3325/cmj.2015.56.351
18. Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47:921-9, doi:10.1016/j. jacc.2005.09.065
19. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461-70, doi:10.7326/0003-4819-130-6-199903160-00002
20. World Health Organization. Nutritional anemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser. 1968;405:5-37.
21. European Stroke Organisation, Tendera M, Aboyans V, Bartelink ML, Baumgartner I, Clément D, et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J. 2011;32:2851-906, doi:10.1093/eurheartj/ehr211
22. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, et al. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. Catheter Cardiovasc Interv. 2012;79:501-31, doi: 10.1161/CIR. 0b013e31822e80c3
23. American Diabetes Association. Standards of medical care in diabetes 2015. Diabetes Care. 2015;38 Suppl 1:S1-93.
24. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Practice Guidelines for the Management of Arterial Hypertension. Blood Press. 2014; 23:3-16, doi: 10.3109/08037051.2014.868629
25. Thiruvoipati T, Kielhorn CE, Armstrong EJ. Peripheral artery disease in patients with diabetes: epidemiology, mechanisms, and outcomes. World J Diabetes. 2015;6:961-9, doi: 10.4239/wjd.v6.i7.961.
26. Leibson CL, Ransom JE, Olson W, Zimmerman BR, O'Fallon WM, Palumbo PJ. Peripheral arterial disease, diabetes, and mortality. Diabetes Care. 2004;27:2843-9, http://dx.doi.org/10.2337/diacare.27.12.2843
27. Golledge J, Quigley F, Velu R, Walker PJ, Moxon JV. Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study. Cardiovasc Diabetol. 2014;13:147, doi: 10.1186/s12933-014-0147-2.
28. Dormandy J, Heeck L, Vig S. The fate of patients with critical leg ischemia. Semin Vasc Surg. 1999;12:142-7.
29. Aquino R, Johnnides C, Makaroun M, Whittle JC, Muluk VS, Kelley ME, et al. Natural history of claudication: long-term serial follow-up study of 1244 claudicants. J Vasc Surg. 2001; 34:962-70, http://dx.doi.org/10.1067/mva.2001.119749
30. Vogt MT, McKenna M, Anderson SJ, Wolfson SK, Kuller LH. The relationship between ankle-arm index and mortality in older men and women. J Am Geriatr Soc. 1993;41:523-30, doi: 10.1111/j.1532-5415.1993.tb01889
31. Criqui MH, Ho LA, Denenberg JO, Ridker PM, Wassel CL, McDermott MM. Biomarkers in peripheral arterial disease patients and near-and longer-term mortality. J Vasc Surg. 2010; 52:85-90, doi: 10.1016/j.jvs.2010.02.004
32. Vidula H, Tian L, Liu K, Criqui MH, Ferrucci L, Pearce WH, et al. Biomarkers of inflammation and thrombosis as predictors of near-term mortality in patients with peripheral arterial disease: a cohort study. Ann Intern Med. 2008;148:85-93, doi:10.7326/0003-4819-148-2-200801150-00003
33. Mueller T, Hinterreiter F, Luft C, Poelz W, Haltmayer M, Dieplinger B. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg. 2014;59:1291-9, doi: 10.1016/j.jvs.2013.11.063
34. Desormais I, Aboyans V, Bura A, Constans J, Cambou JP, Messas E, et al. Anemia, an independent predictive factor for amputation and mortality in patients hospitalized for peripheral artery disease. Eur J Vasc Endovasc Surg. 2014;48:202-7, doi: 10.1016/j.ejvs.2014.04.005
35. Sefer S, Trotic R, Degoricija V, Vrsalovic M, Ratkovic-Gusic I, Kes P. Healing of skin necrosis and regression of anticardiolipin antibodies achieved by parathyroidectomy in a dialyzed woman with calcific uremic arteriolopathy. Croat Med J. 2001;42:679-82.
36. Mlekusch W, Exner M, Sabeti S, Amighi J, Schlager O, Wagner O, et al. Serum creatinine predicts mortality in patients with peripheral artery disease: influence of diabetes and hypertension. Atherosclerosis. 2004;175:361-7, http://dx.doi.org/10.1016/j.atherosclerosis.2004.04.008
37. Hedberg P, Hammar C, Selmeryd J, Viklund J, Leppert J, Hellberg A, et al. Leftventricular systolic dysfunction in outpatients with peripheral atherosclerotic vascular disease: prevalence and association with location of arterial disease. Eur J Heart Fail. 2014;16:625-32, doi: 10.1002/ejhf.95
38. Khan TH, Farooqui FA, Niazi K. Critical review of the ankle brachial index. Curr Cardiol Rev. 2008;4:101-6, doi: 10.2174/157340308784245810.